Sponsored Links
| Survival Rates For Metastatic Melanoma Improve With Immune-boosting Interleukin-2 Vaccine |
 |
 |
 |
| Medical News - Dermatology | |||
|
For patients with advanced melanoma, which is the most lethal type of skin cancer, the results of a large clinical trial show that a vaccine combined with the immune-boosting drug Interleukin-2 can improve response rate and progression-free survival. The findings of the study were published in the June 2 issue of New England Journal of Medicine... Read more: Dermatology News From Medical News Today
|